contraindication for glp 1 contraindications to agonists Ever wondered what the buzz is about GLP -1 agonists? 💡 GLP-1 receptor agonists in people

If someone experiences fewer disruptions or a smoother recovery pattern, it may become easier to maintain activity and nutrition routines

Evidence has mounted over the past decade and in 2021, clinical trials funded by the Danish pharmaceutical company Novo Nordisk started demonstrating significant improvements for MASH patients treated with semaglutide (sold by the company as Ozempic for Type 2 diabetes and Wegovy for weight loss)

PMID 31968661

Sparberg 1990

Weekly injections (e.g., semaglutide, tirzepatide, dulaglutide, and exenatide ER) offer convenience but still require careful titration and consistent day-of-week use